Quetiapine (Seroquel) was more clinically effective than lithium as a first-line augmentation option in treatment-resistant depression and likely was more cost-effective, a pragmatic multicenter ...

Quetiapine augmentation outperforms lithium augmentation in long-term clinical and cost-effectiveness among adults with ...

In the ESCAPE-TRD study, Spravato outperformed quetiapine on the main endpoint of achieving remission at eight weeks, measured by the Montgomery-Åsberg Depression Rating Scale (MADRS), with rates ...

Find all the commercial and brand names of generic drug called Quetiapine. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium.